Checkpoint Therapeutics, Inc.
NASDAQ: CKPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James F. Oliviero III,
- Employees
- 24
- Headquarters
- Waltham, United States
- IPO year
- 2016
- Market cap
- $367.7M
- Website
- https://www.checkpointtx.com
Loading CKPT…
Loading profile data…Frequently asked questions about CKPT
What does Checkpoint Therapeutics, Inc. (CKPT) do?
Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeutic solutions for individuals battling solid tumor cancers. The company's pipeline features several key candidates, including Cosibelimab, a leading...
Where does CKPT trade?
Checkpoint Therapeutics, Inc. (CKPT) trades on the NASDAQ Capital Market.
What sector is CKPT in?
Checkpoint Therapeutics, Inc. (CKPT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Checkpoint Therapeutics, Inc.?
James F. Oliviero III, is the chief executive officer of Checkpoint Therapeutics, Inc. (CKPT).
Where is Checkpoint Therapeutics, Inc. headquartered?
Checkpoint Therapeutics, Inc. is headquartered in United States.
Does CKPT pay a dividend?
Checkpoint Therapeutics, Inc. (CKPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CKPT go public?
Checkpoint Therapeutics, Inc. (CKPT) completed its initial public offering in 2016.